Sagimet Biosciences Presents Clinical Denifanstat and Preclinical FASN Inhibitor Data at ...
Subset analysis of FASCINATE-2 Phase 2 trial demonstrated denifanstat improved fibrosis in difficult-to-treat MASH patients ...